Literature DB >> 25664054

Clinical value of calcium load test in differential diagnosis of different types of hyperparathyroidism.

Xiaoxiao Zhu1, Chang Shan2, Qi Zhu2, Lige Song2, Yun Zhou2, Jia Liu3, Keqin Zhang2.   

Abstract

OBJECTIVE: To investigate the clinical value of calcium load test in the differentiation of various types of hyperparathyroidism (HPT).
METHODS: A total of 56 healthy subjects (Control) and 68 patients with different types of HPT hyperparathyroidism were recruited into this study.
RESULTS: In primary HPT (PHPT) group, the inhibition rate of PTH (PTH-IR) was significantly smaller than those in Control, SHPT1 and CuHPT group (all P = 0.000). There was no significant difference in the PTH-IR among Control, mild secondary HPT (SHPT1) and cause-unknown HPT (CuHPT) group. In severe secondary HPT (SHPT2) group, the PTH-IR was significantly smaller than those in Control (P = 0.005), SHPT1 (P = 0.001) and CuHPT group (P = 0.002), but was similar to that in tertiary HPT (THPT) group (P = 0.644). ROC curve showed PTH-IR of < 71.26% could differentiate PHPT patients from controls; PTH-IR of < 82.26% could differentiate PHPT patients from SHPT1 patients; PTH-IR of < 82.60% could differentiate SHPT1 patients from SHPT2 patients.
CONCLUSION: Calcium load test could effectively differentiate mild PHPT patients from mild SHPT patients and healthy subjects. In SHPT patients, the autonomous tendency of the parathyroid gland gradually increases with the deterioration of impaired renal function, resulting in similar parathyroid response to calcium between severe SHPT and THPT. The autonomous property of the parathyroid gland may become one of the indications for parathyroidectomy in SHPT patients.

Entities:  

Keywords:  Hyperparathyroidism; calcium load test; differentiation

Year:  2014        PMID: 25664054      PMCID: PMC4307501     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  21 in total

1.  K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease.

Authors: 
Journal:  Am J Kidney Dis       Date:  2003-10       Impact factor: 8.860

Review 2.  Clinical lessons from the calcium-sensing receptor.

Authors:  Edward M Brown
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2007-02

3.  Asymptomatic primary hyperparathyroidism discovered by multichannel biochemical screening: clinical course and considerations bearing on the need for surgical intervention.

Authors:  A M Parfitt; D S Rao; M Kleerekoper
Journal:  J Bone Miner Res       Date:  1991-10       Impact factor: 6.741

4.  Clinical practice guideline for the management of chronic kidney disease-mineral and bone disorder.

Authors:  Masafumi Fukagawa; Keitaro Yokoyama; Fumihiko Koiwa; Masatomo Taniguchi; Tetsuo Shoji; Junichiro James Kazama; Hirotaka Komaba; Ryoichi Ando; Takatoshi Kakuta; Hideki Fujii; Msasaaki Nakayama; Yugo Shibagaki; Seiji Fukumoto; Naohiko Fujii; Motoshi Hattori; Akira Ashida; Kunitoshi Iseki; Takashi Shigematsu; Yusuke Tsukamoto; Yoshiharu Tsubakihara; Tadashi Tomo; Hideki Hirakata; Tadao Akizawa
Journal:  Ther Apher Dial       Date:  2013-06       Impact factor: 1.762

5.  Lack of biochemical progression or continuation of accelerated bone loss in mild asymptomatic primary hyperparathyroidism: evidence for biphasic disease course.

Authors:  D S Rao; R J Wilson; M Kleerekoper; A M Parfitt
Journal:  J Clin Endocrinol Metab       Date:  1988-12       Impact factor: 5.958

Review 6.  Current indications to parathyroidectomy in CKD patients before and after renal transplantation.

Authors:  Piergiorgio Messa; Anna Regalia; Carlo Maria Alfieri; Donata Cresseri; Laura Forzenigo; Maria Teresa Gandolfo; Maria Pia Rastaldi
Journal:  J Nephrol       Date:  2013-11-19       Impact factor: 3.902

7.  Tertiary hyperparathyroidism: histologic patterns of disease and results of parathyroidectomy.

Authors:  Electron Kebebew; Quan-Yang Duh; Orlo H Clark
Journal:  Arch Surg       Date:  2004-09

8.  Stimulation and suppression of intact parathyroid hormone (PTH1-84) in normal subjects and hyperparathyroid patients.

Authors:  P Lips; J C Netelenbos; L van Doorn; W H Hackeng; C J Lips
Journal:  Clin Endocrinol (Oxf)       Date:  1991-07       Impact factor: 3.478

9.  Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism.

Authors:  O Kifor; F D Moore; P Wang; M Goldstein; P Vassilev; I Kifor; S C Hebert; E M Brown
Journal:  J Clin Endocrinol Metab       Date:  1996-04       Impact factor: 5.958

10.  Acute effects of calcium carbonate and citrate on secondary hyperparathyroidism in chronic renal failure.

Authors:  H Saha; K Pietilä; J Mustonen; A Pasternack; P Mörsky; E Seppälä; P Reinikainen
Journal:  Am J Nephrol       Date:  1991       Impact factor: 3.754

View more
  2 in total

1.  Parathyroid hormone and calcitonin response during the calcium infusion test in patients with primary hyperparathyroidism.

Authors:  Emir Muzurović; Karin Zibar Tomšić; Snežana Vujošević; Milan Petakov
Journal:  Hormones (Athens)       Date:  2022-02-01       Impact factor: 2.885

Review 2.  Diagnosis, management, histology and genetics of sporadic primary hyperparathyroidism: old knowledge with new tricks.

Authors:  Maria Mizamtsidi; Constantinos Nastos; George Mastorakos; Roberto Dina; Ioannis Vassiliou; Maria Gazouli; Fausto Palazzo
Journal:  Endocr Connect       Date:  2018-01-12       Impact factor: 3.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.